Paying user area
Try for free
Express Scripts Holding Co. pages available for free this week:
- Analysis of Solvency Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Reportable Segments
- Common Stock Valuation Ratios
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Price to Earnings (P/E) since 2005
- Price to Operating Profit (P/OP) since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Express Scripts Holding Co. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Operating profit margin | = | 100 | × | Operating income1 | ÷ | Revenues1 | |
---|---|---|---|---|---|---|---|
Dec 31, 2017 | = | 100 | × | ÷ | |||
Dec 31, 2016 | = | 100 | × | ÷ | |||
Dec 31, 2015 | = | 100 | × | ÷ | |||
Dec 31, 2014 | = | 100 | × | ÷ | |||
Dec 31, 2013 | = | 100 | × | ÷ | |||
Dec 31, 2012 | = | 100 | × | ÷ | |||
Dec 31, 2011 | = | 100 | × | ÷ | |||
Dec 31, 2010 | = | 100 | × | ÷ | |||
Dec 31, 2009 | = | 100 | × | ÷ | |||
Dec 31, 2008 | = | 100 | × | ÷ | |||
Dec 31, 2007 | = | 100 | × | ÷ | |||
Dec 31, 2006 | = | 100 | × | ÷ | |||
Dec 31, 2005 | = | 100 | × | ÷ |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
- Operating Income
- The operating income demonstrates a consistent upward trajectory over the period analyzed. Starting at $643 million in 2005, it increased steadily each year, reaching approximately $5.49 billion by the end of 2017. This signifies considerable growth, with the operating income rising more than eightfold over twelve years, indicating improved operational efficiency or successful scale expansion.
- Revenues
- Revenues increased notably throughout the period, starting at around $16.27 billion in 2005 and surging to about $100.06 billion in 2017. There is an especially sharp increase between 2009 and 2012, with revenue roughly quadrupling from approximately $24.75 billion to $93.86 billion. This sharp rise suggests significant business growth, likely driven by acquisitions, expanded services, or increased market share. After 2012, revenues appear relatively stable with minor fluctuations, holding steady around the $100 billion mark through to 2017.
- Operating Profit Margin
- The operating profit margin shows variability throughout the timeframe. It generally increases from 3.95% in 2005 to a peak of 6.05% in 2009, reflecting improved profitability during this early period. However, there is a notable dip after 2009, dropping sharply to 2.97% in 2012. This decline may be related to the rapid growth in revenues during this time, possibly indicating higher operating costs associated with scaling operations. Following 2012, the margin improves progressively, reaching 5.49% by 2017, suggesting that the company managed to enhance operational efficiencies and recover profitability after the initial dip.
- Overall Trends and Insights
- The data reveals robust revenue and operating income growth over the twelve-year period, underscored by a remarkable expansion phase between 2009 and 2012. Despite this growth, profitability as measured by the operating margin experienced volatility, with a notable decline coinciding with the revenue surge, likely reflecting the challenges of integrating new business or managing increased costs. However, the recovery and steady improvement in operating margin from 2012 onward indicate successful adaptation and improved earnings quality. These patterns suggest a phase of rapid expansion followed by consolidation and operational refinement.
Comparison to Competitors
Express Scripts Holding Co. | Abbott Laboratories | CVS Health Corp. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|
Dec 31, 2017 | ||||||
Dec 31, 2016 | ||||||
Dec 31, 2015 | ||||||
Dec 31, 2014 | ||||||
Dec 31, 2013 | ||||||
Dec 31, 2012 | ||||||
Dec 31, 2011 | ||||||
Dec 31, 2010 | ||||||
Dec 31, 2009 | ||||||
Dec 31, 2008 | ||||||
Dec 31, 2007 | ||||||
Dec 31, 2006 | ||||||
Dec 31, 2005 |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).